[1]EuropeanJournalofMedicinalChemistry,1998,vol.33,p.867-877
13414-95-4
5650-52-2
851634-60-1
24444-98-2
1864061-40-4
13129-17-4
147126-58-7 | β-D-Glucopyranoside, octyl 2-(acetylamino)-2-deoxy- | AA001EJW | MFCD04039658
147531-11-1 | Diphenyl(trifluoromethyl)sulfonium trifluoromethanesulfonate | AA001EVG | MFCD12912173
14779-17-0 | 2-Amino-5-methylbenzothiazole | AA001F4S | MFCD00205354
148148-48-5 | Benzyl 4-[methoxy(methyl)carbamoyl]piperidine-1-carboxylate | AA001FEO | MFCD07370044
141-97-9 | Ethyl acetoacetate | AA001FOK | MFCD00009199
14150-95-9 | 2-Aminopyridine n-oxide | AA001GFF | MFCD00059168
1416440-37-3 | 3-(Methylthio)-1h-indol-5-amine | AA001GQD | MFCD22690534
1419075-83-4 | 4-Bromo-2-fluoro-3-(trifluoromethoxy)benzoic acid | AA001H9A | MFCD23140378
1420790-22-2 | 8-Bromo-7-fluoroquinoline | AA001HN5 | MFCD22688813
142266-62-4 | 2,5,6-Trichloronicotinamide | AA001I09 | MFCD22493418